Thrombopoietic agent

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Thrombopoietic agents are drugs that induce the growth and maturation of megakaryocytes.[1] Some of them are currently in clinical use: romiplostim,[2] eltrombopag, oprelvekin (a recombinant interleukin 11) and thrombopoietin. Several others are under clinical investigation such as lusutrombopag and avatrombopag.

References[edit]

  1. ^ Michael Clinton Perry. The Chemotherapy Source Book. Lippincott Williams & Wilkins, 2008 pg. 51
  2. ^ Romiplostim